AIP
JBIO

Ameritas Investment Partners’s Jade Biosciences JBIO Stock Holding History

Ameritas Investment Partners’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.6K Sell
2,608
-704
-21% -$10.2K ﹤0.01% 2282
2025
Q4 		$51.1K Hold
3,312
– – ﹤0.01% 2101
2025
Q3 		$28.6K Hold
3,312
– – ﹤0.01% 2507
2025
Q2 		$33.1K Buy
3,312
+3,290
+14,955% +$112K ﹤0.01% 2437
2025
Q1 		$1.94K Hold
22
– – ﹤0.01% 3071
2024
Q4 		$2.05K Hold
22
– – ﹤0.01% 3098
2024
Q3 		$1.61K Hold
22
– – ﹤0.01% 3104
2024
Q2 		$1.28K Hold
22
– – ﹤0.01% 3105
2024
Q1 		$22.8K Hold
22
– – ﹤0.01% 2510
2023
Q4 		$17.5K Hold
22
– – ﹤0.01% 2639
2023
Q3 		$10.5K Hold
22
– – ﹤0.01% 2828
2023
Q2 		$13.2K Hold
22
– – ﹤0.01% 2789
2023
Q1 		$15.6K Hold
22
– – ﹤0.01% 2548
2022
Q4 		$17.8K Hold
22
– – ﹤0.01% 2609
2022
Q3 		$12K Hold
22
– – ﹤0.01% 2735
2022
Q2 		$12K Hold
22
– – ﹤0.01% 2773
2022
Q1 		$14K Hold
22
– – ﹤0.01% 2678
2021
Q4 		$9K Hold
22
– – ﹤0.01% 2923
2021
Q3 		$16K Buy
+22
New +$12.3K ﹤0.01% 2796

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameritas Investment Partners's JBIO Position: Q1 2026 in Review

Ameritas Investment Partners reduced its Jade Biosciences (JBIO) stake by 21% in Q1 2026, selling an estimated $10.2K and leaving 2,608 shares worth $36.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2282.

Ameritas Investment Partners first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $51.1K in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Ameritas Investment Partners held 2,608 shares of Jade Biosciences worth $36.6K as of Q1 2026.
  • Ameritas Investment Partners sold 704 Jade Biosciences shares in Q1 2026, an estimated $10.2K.
  • Jade Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2282 holding.
  • Ameritas Investment Partners first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Ameritas Investment Partners's Jade Biosciences position peaked at $51.1K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.